Free tool
Oncology stocks
We cover 4 companies grouped under the Oncology theme. The median market value in the group is $385.85M. Across the group, the median move over the past trading day is +1.54%. Price change over the past year runs from −34.1% to +393.7% across the middle 80 percent of the group, with a median of +27.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 4587.T | PeptiDream Inc. | $902.75M | Small cap | −28.26% |
| 4588.T | Oncolys BioPharma Inc. | $716.01M | Small cap | +526.71% |
| 4572.T | Carna Biosciences, Inc. | $55.69M | Micro cap | +83.26% |
| 4583.T | Chiome Bioscience Inc. | $42.82M | Micro cap | −36.57% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.